Everence Capital Management Inc. Sells 1,630 Shares of Select Medical Holdings Co. (NYSE:SEM)

Everence Capital Management Inc. decreased its stake in Select Medical Holdings Co. (NYSE:SEM) by 9.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 15,210 shares of the health services provider’s stock after selling 1,630 shares during the period. Everence Capital Management Inc.’s holdings in Select Medical were worth $287,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP raised its holdings in shares of Select Medical by 2.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock worth $157,728,000 after purchasing an additional 95,578 shares during the period. Geode Capital Management LLC grew its stake in shares of Select Medical by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after acquiring an additional 46,880 shares during the period. Principal Financial Group Inc. raised its stake in Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after acquiring an additional 147,032 shares during the period. Point72 Asset Management L.P. lifted its holdings in Select Medical by 144.2% during the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Select Medical by 1.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after purchasing an additional 24,439 shares during the period. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Stock Up 1.3 %

SEM opened at $18.65 on Wednesday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical Holdings Co. has a one year low of $18.02 and a one year high of $40.98. The firm has a market capitalization of $2.41 billion, a P/E ratio of 8.71, a price-to-earnings-growth ratio of 0.39 and a beta of 1.45. The company has a fifty day moving average price of $26.63 and a 200-day moving average price of $32.08.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.46 EPS. Equities research analysts expect that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 2.68%. Select Medical’s payout ratio is presently 23.36%.

Insiders Place Their Bets

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares in the company, valued at $463,980. The trade was a 59.26 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the transaction, the vice president now directly owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Royal Bank of Canada upped their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, UBS Group decreased their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $39.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.